Ischemia times and donor serum creatinine in relation to renal graft failure
暂无分享,去创建一个
W. Weimar | J. Ijzermans | T. van Gelder | P. Mulder | W Weimar | J. Roodnat | I. V. van Riemsdijk | J I Roodnat | P G H Mulder | I C Van Riemsdijk | J N M IJzermans | T van Gelder
[1] A. Matas,et al. Living donors >55 years: to use or not to use? , 1999, Transplantation.
[2] L. Ratner,et al. Impact of donor/recipient traits independent of rejection on long-term renal function. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] D. Slakey,et al. Baseline glomerular size as a predictor of function in human renal transplantation. , 1998, Transplantation.
[4] M. Joffe,et al. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. , 2001, The New England journal of medicine.
[5] J. Chapman,et al. EFFECT OF HISTOLOGICAL DAMAGE ON LONG-TERM KIDNEY TRANSPLANT OUTCOME , 2001, Transplantation.
[6] J. Cecka. The UNOS Scientific Renal Transplant Registry. , 1999, Clinical transplants.
[7] P. Fauchald,et al. Unrelated living donors in 141 kidney transplantations: a one-center study. , 1998, Transplantation.
[8] D. Gjertson. A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS Update. , 1996, Clinical transplants.
[9] F. Port,et al. Relationship of recipient age and development of chronic allograft failure. , 2000, Transplantation.
[10] A. Matas,et al. Living unrelated donors in kidney transplants: better long-term results than with non-HLA-identical living related donors? , 1999, Transplantation.
[11] W. Lye,et al. Biopsy-proven resolution of steroid-resistant acute rejection with basiliximab therapy in a renal allograft recipient. , 2001, Transplantation proceedings.
[12] J Karpinski,et al. Outcome of kidney transplantation from high-risk donors is determined by both structure and function. , 1999, Transplantation.
[13] S. Hariharan,et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. , 2000, The New England journal of medicine.
[14] J. Carter,et al. Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation. , 2000, Archives of surgery.
[15] H. Wolters,et al. Basiliximab in the therapy of acute rejection after organ transplantation. , 2001, Transplantation proceedings.
[16] R. Zietse,et al. The vanishing importance of age in renal transplantation. , 1999, Transplantation.
[17] S Takemoto,et al. High survival rates of kidney transplants from spousal and living unrelated donors. , 1995, The New England journal of medicine.
[18] J. Heaf,et al. Hyperfiltration, creatinine clearance and chronic graft loss. , 1998, Clinical transplantation.
[19] R. Zietse,et al. The impact of donor age on renal graft survival. , 2000, Transplantation proceedings.
[20] B D Kahan,et al. The impact of HLA mismatches on the survival of first cadaveric kidney transplants. , 1994, The New England journal of medicine.
[21] B. Brenner,et al. Antigen-independent determinants of cadaveric kidney transplant failure. , 1996, JAMA.
[22] M. Burdelski,et al. First experience with basiliximab in pediatric liver graft recipients , 2001, Pediatric transplantation.
[23] O. Schück,et al. Adverse effect of donor arteriolosclerosis on graft outcome after renal transplantation. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[24] J. Mcgregor,et al. An alternative approach for statistical analysis of kidney transplant data: multivariate analysis of single-center experience. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] B. Brenner,et al. Antigen-independent determinants of graft survival in living-related kidney transplantation. , 1997, Kidney international. Supplement.
[26] E. Messing,et al. Living Related and Unrelated Donors for Kidney Transplantation A 28‐Year Experience , 1995, Annals of surgery.
[27] H. Isoniemi,et al. Histopathological findings in renal allografts at time of transplantation and correlation with onset of graft function* , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[28] J. Carter,et al. EVALUATION OF THE OLDER CADAVERIC KIDNEY DONOR: THE IMPACT OF DONOR HYPERTENSION AND CREATININE CLEARANCE ON GRAFT PERFORMANCE AND SURVIVAL12 , 2000, Transplantation.
[29] T. Peters,et al. Cold Ischemia And Outcome In 17,937 Cadaveric Kidney Transplants , 1995, Transplantation.
[30] J. C. Houwelingen,et al. PROGNOSTIC INDICES TO PREDICT SURVIVAL OF FIRST AND SECOND RENAL ALLOGRAFTS , 1991, Transplantation.
[31] H. V. van Houwelingen,et al. Permanent detrimental effect of nonimmunological factors on long-term renal graft survival: a parsimonious model of time-dependency. , 1999, Transplantation.
[32] K. Uchida,et al. Histological factors of 1-h biopsy influencing the delayed renal function and outcome in cadaveric renal allografts. , 1999, Clinical transplantation.
[33] U. Neumann,et al. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation. , 1998, Clinical transplantation.
[34] P. Dyer,et al. Importance of minimizing HLA-DR mismatch and cold preservation time in cadaveric renal transplantation. , 1996, Transplantation.
[35] A. Lu,et al. Severe glomerular sclerosis is not associated with poor outcome after kidney transplantation. , 2000, American journal of surgery.
[36] N Bilgin,et al. Living unrelated donor kidney transplantation. , 1992, Transplantation Proceedings.
[37] W. Weimar,et al. Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantation. , 1999, Transplantation.
[38] S. Greenstein,et al. Reassessment of the value of post-vascularization biopsy performed at renal transplantation: the effects of arteriosclerosis. , 1994, The Journal of urology.